Records containing: Osteosarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-29A Phase II, Randomized, Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics (PK) of Maintenance Cabozantinib (XL184) Plus Best Supportive Care (BSC) Versus BSC in Children, Adolescents and Young Adults (AYA) With Unresectable Residual Osteosarcoma Either at Diagnosis or at First Relapse After Standard Treatment
-
CLINICAL_TRIALS study record update · 2026-10-19A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of HS-20093 for Injection Versus Gemcitabine in Combination With Docetaxel in the Treatment of Osteosarcoma After Previous Second-line Treatment Failure (ARTEMIS-011)
-
CLINICAL_TRIALS study record update · 2026-04-24Methionine PET/CT Studies In Patients With Cancer
-
CLINICAL_TRIALS study record update · 2026-04-23Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-22Vaccination to Enhance the Anti-Tumor Activity of GD2 Chimeric Antigen Receptor-Expressing, VZV-Specific T Cells in Subjects With Advanced Sarcomas and Neuroblastoma (VEGAS)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-17Assessment of Healing and Function After Surgical Reconstruction for Neoplasms Involving Bone
-
CLINICAL_TRIALS study record update · 2026-04-15Phase II Basket Study to Evaluate the Tissue-agnostic Efficacy of Anti-Programmed Cell Death Protein 1 (Anti-PD1) Monoclonal Antibody in Patients With Advanced Rare Tumors
-
CLINICAL_TRIALS study record update · 2026-04-15B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
-
CLINICAL_TRIALS study record update · 2026-04-15Musculoskeletal Cancers Remote Monitoring and Care
-
CLINICAL_TRIALS study record update · 2026-04-13A Dose Escalation Study Using Eflornithine (DFMO) and AMXT 1501 Followed by a Randomized Controlled Trial of DFMO With or Without AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 2 Study of DS-8201a (NSC# 807708) in Adolescents, or Young Adults With Recurrent HER2+ Osteosarcoma
-
CLINICAL_TRIALS study record update · 2026-04-09Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-09A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of HS-20093 for Injection Versus Gemcitabine in Combination With Docetaxel in the Treatment of Osteosarcoma After Previous Second-line Treatment Failure (ARTEMIS-011)
-
CLINICAL_TRIALS study record update · 2026-04-08my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase 1/2 Dose Escalation and Dose Expansion Study of ZN-c3 in Combination With Gemcitabine in Adult and Pediatric Subjects With Relapsed or Refractory Osteosarcoma
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase II, Randomized, Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics (PK) of Maintenance Cabozantinib (XL184) Plus Best Supportive Care (BSC) Versus BSC in Children, Adolescents and Young Adults (AYA) With Unresectable Residual Osteosarcoma Either at Diagnosis or at First Relapse After Standard Treatment
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase I Study of Autologous Activated T-Cells Expressing a 2nd Generation GD2 Chimeric Antigen Receptor, IL-15, and iCaspase9 Safety Switch Administered To Patients With Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
-
CLINICAL_TRIALS study record update · 2026-03-25Evaluation of the Efficacy and Safety of Regorafenib in Patients With Refractory Primary Bone Tumors
-
CLINICAL_TRIALS study record update · 2026-03-18Safety and Efficacy of Apatinib Combined With Irinotecan Liposome Injection in the Treatment of Recurrent or Metastatic Osteosarcoma: A Single-Arm, Open-Label, Prospective Multicenter Clinical Study
-
CLINICAL_TRIALS study record update · 2026-03-18Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
-
CLINICAL_TRIALS study record update · 2026-03-18An Open-Label, Dose Escalation, Efficacy, and Safety Study of CLR 131 in Children, Adolescents, and Young Adults With Select Solid Tumors, Lymphoma, and Malignant Brain Tumors
-
CLINICAL_TRIALS study record update · 2026-03-17OstEvo - Osteosarcoma Evolves
-
CLINICAL_TRIALS study record update · 2026-03-16Functional Outcomes in Patients Who Undergo Upfront Surgical Resection for High-Grade Osteosarcoma of the Extremity: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-03-11Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-04BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast